CClinicalTrials.gg
CompletedNCT02702661Updated Mar 11, 2016

PRCT of FICB vs LAI for Hip Arthroscopy

An interventional study of Fascia Iliaca Compartment Block (FICB) and Local Anaesthetic Infiltration (LAI) in Femoroacetabular Impingement, sponsored by Cambridge University Hospitals NHS Foundation Trust. Completed. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2016-03-11.

Sponsored by Cambridge University Hospitals NHS Foundation Trust · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
46
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

A prospective randomised controlled trial involving patients undergoing hip arthroscopy. Participants were randomised to receiving either Fascia Iliaca Compartment Block (FICB) or Local Anaesthetic Infiltration (LAI) of the portal tracts with local anaesthetic. Supplemental analgesia was also used in both groups on an on-demand basis. Pain level is assessed at 1,3,6, and 24 hours post surgery. The primary outcome measure was the post-operative level of pain as assessed by Numeric Pain Score 6 hours after surgery. Secondary outcome measures were the frequency and the dose of morphine and other medications consumed at 1 and 24 hours after surgery as well as any other adverse events relating to pain or medications used for pain relief in both the groups.

02

Conditions studied

  • Femoroacetabular Impingement

Keywords

  • Fascia Iliaca Block
  • Local Anaesthetic Infiltration
  • Hip Arthroscopy
03

In context

Femoracetabular Impingement

108 studies on the registry are indexed under Femoracetabular Impingement; 35 are open to participants now.

This study's enrollment of 46 is below the median of 75 across 63 interventional studies indexed under Femoracetabular Impingement.

Browse Femoracetabular Impingement studies →

Lead sponsor

Cambridge University Hospitals NHS Foundation Trust is the lead sponsor of 167 studies on the registry; 37 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients over the age of 18 years
  • Primary elective hip arthroscopy on a native hip for combined soft tissue injuries and FAI pathology
  • Able to read, write and communicate in English

Exclusion criteria

Exclusion Criteria:

  • Patients who did not want to be involved in the Trial
  • Unable to give informed consent
  • Previous hip surgery
  • Patients younger than 18 years of age
  • Chronic opioids users
  • Patients known to have an allergy or intolerance to local anaesthetic agents or none steroidal anti-inflammatory medications
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
46 participants (actual)

Study arms

  • Experimental
    Procedure - FICB

    Fascia Iliaca Block following Hip Arthroscopy - Drug - Levobupivacaine 0.125% - 40ml

    Procedure: Fascia Iliaca Compartment Block (FICB) · Drug: Levobupivacaine

  • Active comparator
    Procedure - LAI

    Local Anaesthetic Infiltration following Hip Arthroscopy - Drug - Levobupivacaine 0.125% - 40ml

    Procedure: Local Anaesthetic Infiltration (LAI) · Drug: Levobupivacaine

Interventions

  • ProcedureFascia Iliaca Compartment Block (FICB)

    Fascia Iliaca Compartment Block

  • ProcedureLocal Anaesthetic Infiltration (LAI)

    Local Anaesthetic Infiltration (LAI) of the portal tracts

  • DrugLevobupivacaine

    Levobupivacaine 0.125% - 40ml

06

What researchers measure

Primary outcomes

  1. Level of pain as assessed by Numeric Pain Score

    Time frame: 6 hours after surgery

Secondary outcomes

  1. Frequency of morphine consumed

    Time frame: 1 and 24 hours after surgery

  2. Total dose of morphine consumed

    Time frame: 1 and 24 hours after surgery

  3. Total dose of codeine consumed

    Time frame: 1 and 24 hours after surgery

  4. Nausea and Vomiting

    Time frame: 1 and 24 hours after surgery

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Mar 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02702661
Lead sponsor
Cambridge University Hospitals NHS Foundation Trust
Responsible party
Vikas Khanduja MA FRCS (Orth) (Consultant Orthopaedic Surgeon & Associate Lecturer, Cambridge University Hospitals NHS Foundation Trust) — Principal investigator
First posted
Mar 9, 2016
Start date
Mar 2013
Primary completion
Nov 2013
Completion
Apr 2014
Last update
Mar 11, 2016

Study contacts

Vikas Khanduja, MA, FRCS (Orth)
study director · Cambridge University Hospitals NHS Foundation Trust

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion